Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients.

Front Immunol · 2024 · PMC11683115 · PMID 39737175

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Co-administration of MTX showed a trend towards a reduced risk; however, the difference narrowly missed reaching statistical significance (HR 0.19, 95% CI 0.03–1.08, P=0.061).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.